| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |